NASDAQ:ELEV
Delisted

Elevation Oncology Stock Signals

etoro logo Buy ELEV
*Your capital is at risk
$0.365
+0 (+0%)
At Close: Oct 22, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Elevation Oncology, Inc.

General

Signal Type Signal Value Data
Score 0.000 64 days ( 0 %
Last Price $0.365 0 %
Performance History
7 Days
$0.365 $0.365
0%
30 Days
$0.365 $0.365
0%
12 Mos
$0.654 $0.365
-44.16%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 30.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.365 - $0.365
Trend - 3 mos 0 % High Width: 0.00000000000021 %
Pred. range - 3 mos $0.365 - $0.365 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Oct 21, 2025 - 2 days
RSI Short Pivot Signal Buy Very Low Aug 04, 2025 - 57 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.1
Signal Type Signal Value Importance Data
Trend - 12 mos -39.07 % Very High Width: 1,337.15 %
Pred. range - 12 mos $0.0235 - $0.338 High -93.55 % - -7.36 %
Short MA 12 mos Buy Very High Jul 11, 2025 - 73 days
Long MA 12 mos Sell Very High Oct 17, 2025 - 4 days
Short/Long MA 12 mos Sell Very High Oct 17, 2025 - 4 days
Pivot Long Buy Low Jul 22, 2025 - 66 days
RSI Long Pivot Signal Buy Low Aug 13, 2025 - 50 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ELEVATION ONCOLOGY, INC.
Elevation Oncology
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is bas...
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE